WallStreetZenWallStreetZen

NYSE: ARDT
Ardent Health Partners Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ARDT

Based on 7 analysts offering 12 month price targets for Ardent Health Partners Inc

Min Forecast
$14.60+27.29%
Avg Forecast
$19.23+67.65%
Max Forecast
$22.00+91.8%

Should I buy or sell ARDT stock?

Based on 7 analysts offering ratings for Ardent Health Partners Inc.

Strong Buy
Strong Buy
4 analysts 57.14%
Buy
2 analysts 28.57%
Hold
0 analysts 0%
Sell
1 analysts 14.29%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their ARDT stock forecasts and price targets.

ARDT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-07
lockedlocked$00.00+00.00%2025-07-16
lockedlocked$00.00+00.00%2025-05-20
lockedlocked$00.00+00.00%2025-05-15
lockedlocked$00.00+00.00%2025-05-09
Mizuho
Top 11%
90
BuyMaintains$18.00+56.93%2025-04-09Find out why
Stephens & Co.
Bottom 49%
49
Strong BuyReiterates$22.00+91.80%2025-02-27

1 of 1

Forecast return on equity

Is ARDT forecast to generate an efficient return?

Company
32.85%
Industry
-99.7%
Market
-48.31%
ARDT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ARDT forecast to generate an efficient return on assets?

Company
8.2%
Industry
10.74%
ARDT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ARDT earnings per share forecast

What is ARDT's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$1.90+1.94%
Avg 2 year Forecast
$2.09+12.29%
Avg 3 year Forecast
$2.29+23.12%
ARDT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ARDT revenue forecast

What is ARDT's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$6.3B+2.07%
Avg 2 year Forecast
$6.7B+7.76%
Avg 3 year Forecast
$7.0B+13.72%
ARDT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ARDT earnings growth forecast

How is ARDT forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
7.14%
Industry
10.01%
Market
15.26%
ARDT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ARDT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ARDT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ARDT revenue growth forecast

How is ARDT forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
4.36%
Industry
4.32%
Market
11.01%
ARDT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ARDT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ARDT vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
ARDT$11.47$19.23+67.65%Strong Buy
ACHC$18.20$39.08+114.74%Strong Buy
PACS$11.09N/AN/A
BKD$7.13$8.33+16.87%Buy
LFST$3.86$8.50+120.21%Strong Buy
View Top Medical Care Facility Stocks

Ardent Health Partners Stock Forecast FAQ

Is Ardent Health Partners Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NYSE: ARDT) stock is to Strong Buy ARDT stock.

Out of 7 analysts, 4 (57.14%) are recommending ARDT as a Strong Buy, 2 (28.57%) are recommending ARDT as a Buy, 0 (0%) are recommending ARDT as a Hold, 1 (14.29%) are recommending ARDT as a Sell, and 0 (0%) are recommending ARDT as a Strong Sell.

If you're new to stock investing, here's how to buy Ardent Health Partners stock.

What is ARDT's earnings growth forecast for 2025-2027?

(NYSE: ARDT) Ardent Health Partners's forecast annual earnings growth rate of 7.14% is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 10.01%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.26%.

Ardent Health Partners's earnings in 2025 is $254,859,000.On average, 5 Wall Street analysts forecast ARDT's earnings for 2025 to be $271,329,824, with the lowest ARDT earnings forecast at $261,884,798, and the highest ARDT earnings forecast at $287,643,958. On average, 7 Wall Street analysts forecast ARDT's earnings for 2026 to be $298,892,125, with the lowest ARDT earnings forecast at $247,574,153, and the highest ARDT earnings forecast at $332,006,957.

In 2027, ARDT is forecast to generate $327,713,764 in earnings, with the lowest earnings forecast at $290,506,087 and the highest earnings forecast at $369,214,633.

What is ARDT's revenue growth forecast for 2025-2027?

(NYSE: ARDT) Ardent Health Partners's forecast annual revenue growth rate of 4.36% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.01%.

Ardent Health Partners's revenue in 2025 is $6,198,620,000.On average, 4 Wall Street analysts forecast ARDT's revenue for 2025 to be $905,465,258,055, with the lowest ARDT revenue forecast at $903,717,212,805, and the highest ARDT revenue forecast at $908,339,551,043. On average, 4 Wall Street analysts forecast ARDT's revenue for 2026 to be $955,902,982,194, with the lowest ARDT revenue forecast at $950,942,340,315, and the highest ARDT revenue forecast at $961,618,081,261.

In 2027, ARDT is forecast to generate $1,008,738,025,533 in revenue, with the lowest revenue forecast at $1,000,314,064,530 and the highest revenue forecast at $1,018,288,234,273.

What is ARDT's forecast return on assets (ROA) for 2025-2028?

(NYSE: ARDT) forecast ROA is 8.2%, which is lower than the forecast US Medical Care Facilities industry average of 10.74%.

What is ARDT's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ARDT price target, the average ARDT price target is $19.23, with the highest ARDT stock price forecast at $22.00 and the lowest ARDT stock price forecast at $14.60.

On average, Wall Street analysts predict that Ardent Health Partners's share price could reach $19.23 by Aug 7, 2026. The average Ardent Health Partners stock price prediction forecasts a potential upside of 67.65% from the current ARDT share price of $11.47.

What is ARDT's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: ARDT) Ardent Health Partners's current Earnings Per Share (EPS) is $1.86. On average, analysts forecast that ARDT's EPS will be $1.90 for 2025, with the lowest EPS forecast at $1.83, and the highest EPS forecast at $2.01. On average, analysts forecast that ARDT's EPS will be $2.09 for 2026, with the lowest EPS forecast at $1.73, and the highest EPS forecast at $2.32. In 2027, ARDT's EPS is forecast to hit $2.29 (min: $2.03, max: $2.58).

What is ARDT's forecast return on equity (ROE) for 2025-2028?

(NYSE: ARDT) forecast ROE is 32.85%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.